Olr420 inhibitors represent a fascinating class of chemical compounds primarily known for their ability to modulate specific olfactory receptors, particularly the Olr420 receptor, which is part of the vast family of G protein-coupled receptors (GPCRs). Olfactory receptors, including Olr420, are predominantly expressed in the olfactory epithelium, where they play a crucial role in the detection and discrimination of odorants. The inhibitors of these receptors interact with the receptor's binding site, effectively blocking or altering its ability to detect specific chemical signals. This interaction often involves precise molecular mechanisms, such as competitive binding, allosteric modulation, or covalent attachment, depending on the structure and chemistry of the inhibitor. The study of these inhibitors contributes significantly to the understanding of the structural and functional dynamics of olfactory receptors, offering insights into the broader GPCR signaling pathways, which are integral to numerous biological processes.
The molecular design of Olr420 inhibitors typically involves a high degree of specificity and affinity for the target receptor, requiring an intricate understanding of the receptor's three-dimensional structure and the physicochemical properties of both the inhibitor and receptor. These compounds are often identified through high-throughput screening methods, where large chemical libraries are evaluated for their ability to interact with Olr420. Structural biology techniques, such as X-ray crystallography or cryo-electron microscopy, are frequently employed to elucidate the binding interactions at the atomic level, providing a detailed view of how these inhibitors modulate receptor activity. Furthermore, computational modeling and molecular dynamics simulations play a pivotal role in predicting the behavior of these inhibitors in a biological context, allowing for the optimization of their binding properties and specificity. The study of Olr420 inhibitors thus not only enhances our comprehension of olfactory signal transduction but also broadens the scope of research into GPCR-mediated processes in general.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $74.00 $166.00 | 2 | |
Calcium channel blocker, can indirectly affect GPCR signaling through calcium ion dynamics, potentially impacting Olr420. | ||||||
Candesartan | 139481-59-7 | sc-217825 sc-217825B sc-217825A | 10 mg 100 mg 1 g | $47.00 $94.00 $151.00 | 6 | |
Angiotensin II receptor blocker, might influence GPCR signaling indirectly, impacting Olr420. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
Cardiac glycoside, could alter GPCR signaling indirectly through effects on cardiac muscle contractility, impacting Olr420. | ||||||
Eprosartan | 133040-01-4 | sc-207631 | 10 mg | $169.00 | 1 | |
Angiotensin II receptor antagonist, may modulate GPCR signaling pathways indirectly, affecting Olr420. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Angiotensin II receptor blocker, might modulate GPCR signaling pathways indirectly, impacting Olr420. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Calcium channel blocker, could indirectly affect GPCR signaling through calcium modulation, impacting Olr420. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Beta-adrenergic blocker, may alter GPCR signaling, potentially impacting Olr420. | ||||||
Ramipril | 87333-19-5 | sc-205833 sc-205833A sc-205833B sc-205833C sc-205833D | 500 mg 1 g 2 g 5 g 10 g | $179.00 $245.00 $364.00 $733.00 $1254.00 | 1 | |
ACE inhibitor, might influence GPCR signaling indirectly through effects on the renin-angiotensin system, impacting Olr420. | ||||||
Telmisartan | 144701-48-4 | sc-204907 sc-204907A | 50 mg 100 mg | $72.00 $94.00 | 8 | |
Angiotensin II receptor blocker, could indirectly affect GPCR signaling, impacting Olr420. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Calcium channel blocker, may influence GPCR signaling indirectly through calcium ion dynamics, impacting Olr420. | ||||||